Microbiology · Year 2 · from Microbiology
Case 1: MRSA Infection and Antibiotic Selection
Presentation
A 58-year-old man with type 2 diabetes presents with a painful, swollen, erythematous area on his right thigh that began as a small "pimple" 5 days ago. He has fever (38.8°C), and examination reveals a 6 cm fluctuant abscess with surrounding cellulitis. He has no drug allergies. Incision and drainage is performed, revealing purulent material. Gram stain shows gram-positive cocci in clusters. The wound culture grows Staphylococcus aureus that is resistant to oxacillin. Susceptibility testing shows the organism is sensitive to vancomycin, daptomycin, linezolid, and trimethoprim-sulfamethoxazole.
Clinical Image
Antimicrobial susceptibility testing demonstrating the pattern of a methicillin-resistant Staphylococcus aureus (MRSA) isolate with resistance to beta-lactam antibiotics but susceptibility to alternative agents.
Image Source: Lecture image - antimicrobial susceptibility testing
Questions
- What is the mechanism of methicillin (oxacillin) resistance in this organism?
- Why are all beta-lactam antibiotics ineffective against MRSA, regardless of in vitro susceptibility results?
- What are appropriate antibiotic options for this patient, and what factors guide selection?
- If this patient had a severe penicillin allergy (anaphylaxis), how would that affect your antibiotic choice?
Answers
- Mechanism of methicillin resistance: MRSA resistance is mediated by the mecA gene (or the related mecC gene), which encodes an altered penicillin-binding protein called PBP2a (also known as PBP2'). This modified PBP has low affinity for beta-lactam antibiotics. PBPs are enzymes essential for peptidoglycan cell wall synthesis; normally, beta-lactams inhibit PBPs, leading to defective cell wall synthesis and bacterial death. However, PBP2a can continue to synthesize the cell wall even in the presence of beta-lactam antibiotics because they cannot bind effectively to it. The mecA gene is carried on a mobile genetic element called the staphylococcal cassette chromosome mec (SCCmec).
- Why all beta-lactams are ineffective: The PBP2a protein confers resistance to all beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, because none of them can bind effectively to this altered target. This is true even if laboratory testing might suggest susceptibility to certain beta-lactams - clinical failures occur because PBP2a can compensate for any PBPs that are inhibited. The exception is the new cephalosporin ceftaroline, which was specifically designed to bind PBP2a and is approved for MRSA infections. For this reason, standard beta-lactams should never be used to treat MRSA infections.
- Appropriate antibiotic options:
- For uncomplicated skin abscess after I&D: Oral therapy is often adequate. Options include:
- TMP-SMX (first-line for community-acquired MRSA skin infections)
- Doxycycline
- Clindamycin (if susceptible - check for inducible resistance with D-test)
- For more severe infections (extensive cellulitis, systemic symptoms, or failed outpatient therapy):
- Vancomycin IV - first-line for serious MRSA infections
- Daptomycin - alternative, especially for bacteremia
- Linezolid - oral bioavailability is excellent; useful for step-down therapy
Selection factors include: severity of infection, need for IV vs. oral therapy, renal function, local resistance patterns, and cost.
- Effect of severe penicillin allergy: While beta-lactams are typically avoided in patients with severe penicillin allergy (anaphylaxis), this is actually not clinically relevant for MRSA infections because beta-lactams wouldn't work anyway due to the mecA-mediated resistance. The patient can safely receive vancomycin, daptomycin, linezolid, or TMP-SMX, none of which are beta-lactams and therefore pose no cross-reactivity risk. For MSSA infections in penicillin-allergic patients, options include vancomycin or, for non-IgE-mediated reactions, careful cephalosporin use (cross-reactivity is <2% with cephalosporins, particularly those with dissimilar side chains).